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AbsTrACT
Objectives a new variant of Chlamydia trachomatis 
(nvct) was discovered in Sweden in 2006. the nvct 
has a plasmid deletion, which escaped detection by 
two nucleic acid amplification tests (abbott-roche, ar), 
which were used in 14 of 21 Swedish counties. the 
objectives of this study were to assess when and where 
nvct emerged in Sweden, the proportion of nvct in 
each county and the role of a potential fitness difference 
between nvct and co-circulating wild-type strains 
(wtct).
Methods We used a compartmental mathematical 
model describing the spatial and temporal spread of 
nvct and wtct. We parameterised the model using 
sexual behaviour data and Swedish spatial and 
demographic data. We used Bayesian inference to fit the 
model to surveillance data about reported diagnoses of 
chlamydia infection in each county and data from four 
counties that assessed the proportion of nvct in multiple 
years.
results Model results indicated that nvct emerged in 
central Sweden (Dalarna, gävleborg, Västernorrland), 
reaching a proportion of 1% of prevalent ct infections 
in late 2002 or early 2003. the diagnostic selective 
advantage enabled rapid spread of nvct in the presence 
of high treatment rates. after detection, the proportion 
of nvct decreased from 30%–70% in ar counties and 
5%–20% in counties that Becton Dickinson tests, to 
around 5% in 2015 in all counties. the decrease in nvct 
was consistent with an estimated fitness cost of around 
5% in transmissibility or 17% reduction in infectious 
duration.
Conclusions We reconstructed the course of a natural 
experiment in which a mutant strain of C. trachomatis 
spread across Sweden. Our modelling study provides 
support, for the first time, of a reduced transmissibility 
or infectious duration of nvct. this mathematical model 
improved our understanding of the first nvct epidemic in 
Sweden and can be adapted to investigate the impact of 
future diagnostic escape mutants.
InTrOduCTIOn
A genetic variant of Chlamydia trachomatis was 
discovered in Sweden in mid-September 2006.1 
This variant, now referred to as the new variant of 
C. trachomatis (nvCT), has a 377 base pair deletion 
in the cryptic plasmid,2 which was part of the target 
sequence used by two nucleic acid amplification 
tests (NAATs). The deleted sequence resulted in 
thousands of false negative test results3 and nvCT 
spread undetected in 14 of 21 Swedish counties 
that used the Abbott m2000 (Abbott Laboratories, 
Abbott Park, Illinois, USA) and Cobas Amplicor/
TaqMan 48 (Roche, Branchburg, New Jersey, USA) 
NAATs. The remaining seven Swedish counties 
used another NAAT, ProbeTEC (Becton Dickinson, 
BD, Franklin Lakes, New Jersey, USA) that used a 
different DNA target sequence on the plasmid. At 
the time of its detection in 2006–2007, the propor-
tion of nvCT was between 20% and 65% in coun-
ties using the Abbott-Roche (AR) NAATs, compared 
with 7%–19% in counties using the BD NAAT.3
Testing of archived specimens found the earliest 
evidence of nvCT in Örebro (central Sweden) 
in one of 61 specimens in June 2003,4 but not in 
specimens from 1999 to 2000 in Örebro and from 
2000 to 2001 in Malmö in southern Sweden.5 
Statistical analyses of trends in CT positivity of 
specimens from Örebro from 1999 to 2006 indi-
cated that nvCT increased to non-negligible levels 
between 2001–2002 and 2003–2004.6 There is 
little information about the presence of nvCT in 
other counties before 2006/2007. After the replace-
ment of NAATs with versions that detect nvCT in 
AR counties, the proportion of nvCT had decreased 
to 5%–7% by 2015 in all counties, irrespective of 
the NAAT used.7
The studies published so far leave open questions 
about the dynamics of the emergence, spread and 
decline of nvCT. The timing and place of its emer-
gence remain unknown. It is assumed that a single 
genetic event produced the new variant, which 
initially co-existed with the wild-type CT (wtCT) 
and then spread clonally, evading detection in areas 
that used AR tests.5 Extensive genomic compari-
sons and analyses of morphology, in vitro growth 
kinetics, phenotypic characteristics including anti-
microbial susceptibility and cell tropism did not 
detect any differences in fitness characteristics 
between any examined wtCT strain and nvCT.5 At 
the population level, the fitness of a CT strain can 
be expressed as the average number of secondary 
infections caused by an infected individual, that is, 
the basic reproduction number R0.
8 Hence, differ-
ences in the relative transmissibility or infectious 
duration of a strain would result in either a fitness 
cost or benefit.9 So far, the available data could 
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Table 1 Description of fixed and variable model parameters, and 
model derived quantities
Fixed parameters Value source
 qj Proportion in risk group 0.93, 0.07 13
 cj Partner change rates 0.59, 6.57 13
 γ  Chlamydia clearance rate (per 
year)
0.73 13
 C County where nvCT emerged 1–21 Methods
Variable parameters Prior Posterior*
 ρ Between-county mixing 
dependency on distance
unif(0, 2) 1.10 (0.86 to 1.33)
 α Average fraction of new contacts 
inside of county
unif(0, 1) 0.74 (0.71 to 0.76)
 β Per partnership transmission 
probability
unif(0, 1) 0.92 (0.82 to 0.99)
 ϵ Assortativity index risk groups unif(0, 1) 0.03 (0.00 to 0.13)
 f  Relative fitness of nvCT compared with wtCT
unif(0.7, 1.3) 0.95 (0.94 to 0.96)
 τ  Treatment rate (wtCT) (per year) unif(0, 3) 2.22 (1.87 to 2.49)
 pi Maximal increase of treatment 
rate τ  after October 2006
unif(0, 0.25) 0.00 (0.00 to 0.02)
 ∆ Number of months that the nvCT 
remained undiscovered until 
October 2006
unif(36, 144) 46 (41 to 56)
Model derived quantities Posterior*
Year of emergence November 2002 (January 2002 to April 
2003)
Proportion treated† 0.75 (0.72 to 0.77)
R0 wtCT 1.06 (1.05 to 1.07)
R0 nvCT before discovery 4.06 (3.62 to 4.37)
R0 nvCT after discovery 1.00 (0.99 to 1.02)
Only results for the model in which we assumed that nvCT emerged in Dalarna are 
shown.
*Median, 95% CI.
†Computed as  τ /
(
τ + γ
)
 .
nvCT, new variant of Chlamydia trachomatis; wtCT, wild-type CT.
not determine the relative contributions of potentially altered 
transmission, patterns of sexual mixing between people infected 
with wtCT and nvCT, and changes in testing to the observed 
nationwide increase and subsequent decrease in the proportion 
of nvCT.10
The objectives of this study were to assess when and where 
nvCT emerged in Sweden, the proportion of nvCT in each 
county, and the role of a potential fitness difference between 
nvCT and the co-circulating wtCT strains. To this end, we devel-
oped a mathematical model of CT transmission that was fitted to 
surveillance data about reported diagnoses of chlamydia infec-
tion in each county, and data from four counties that assessed the 
proportion of nvCT in multiple years, using Bayesian inference.
METhOds
data
We used data on the type of NAAT used in Swedish counties. 
From the mid-1990s, chlamydia cell culture was replaced by 
NAAT. In 13 of 21 Swedish counties, AR NAATs were used, in 
seven counties, the BD NAAT system was used and one county, 
Västra Götaland, used the BD NAAT in three of four laborato-
ries and an AR NAAT in a single smaller laboratory. We refer 
to counties according to the NAAT system used, with the suffix 
-AR or -BD. In the model, Västra Götaland is treated as a BD 
county.
We used published data about the proportion of nvCT and 
data about diagnosis rates in different years and counties in 
Sweden. Data about the proportion of nvCT were published for 
seven AR counties and five BD counties just after its discovery 
(late 2006 and early 2007).3 Additional data for 2008, 2009, 
2011 and 2015 were available for four of these 12 counties 
(Dalarna-AR, Örebro-AR, Uppsala-BD and Norrbotten-BD, 
online supplementary table S1).7 We had data about the yearly 
number of CT diagnoses from all counties since 1997.11 In the 
model, we only used CT diagnosis data from Dalarna, Örebro, 
Uppsala and Norrbotten for selected years before and after the 
discovery of nvCT (2004, 2006, 2007, 2008 and 2009, online 
supplementary table S2). We chose this subset of data to give 
the diagnoses rates and the data about the proportion of nvCT 
a similar weight for Bayesian inference. We also anticipated 
that those differences in diagnosis rates between AR counties 
and BD counties, attributable to misdiagnoses by AR NAAT 
before the discovery of nvCT, would be most pronounced in 
years around its discovery. For simplicity, we assumed that 
only people aged 15–29 years were tested. We calculated the 
diagnosis rate for this population by dividing the total number 
of diagnoses by the county-specific yearly population sizes for 
this age group. Population sizes were obtained from Statistics 
Sweden.12
We used spatial data specifying distances between the centroids 
of the counties, which we downloaded as a geographic infor-
mation system shapefile. Lastly, we used sexual behaviour data 
about the yearly number of new heterosexual partners for sexu-
ally experienced people from 15 to 29 years. These data were 
from the second British National Survey of Sexual Attitudes 
and Lifestyles (Natsal-2) because there were no detailed sexual 
behaviour data from Sweden. Natsal-2 is a nationally represent-
ative cross-sectional survey that interviewed 12 110 respondents 
aged 16–44 years (response rate 65.4%) from 1999 to 2001.13 
The data collection period is close to the likely timing of nvCT 
emergence. We did not include data from Natsal-3 (2010–2012) 
as changes in sexual behaviour between the two surveys were 
small.14
Transmission model
We developed a mathematical model to describe the spread of 
nvCT in Sweden (table 1, online supplementary material S1). 
We implemented the spatial structure of Sweden consisting of 
21 counties using a gravity model in a meta-population frame-
work.15–17 We considered the population of Swedish sexually 
experienced heterosexual adults aged 15–29 years, subdivided 
into a low and a high sexual activity class (online supplemen-
tary figure S1). Individuals can be infected with either wtCT or 
nvCT. We assumed that wtCT is representative of all CT strains 
that are co-circulating with nvCT. Susceptible people seek sexual 
partners at rate c. The per partnership transmission probability 
of wtCT and nvCT is  β  and  fβ , respectively, where  f   can account 
for a potential difference in transmissibility of nvCT. Infected 
people clear infection naturally at rate  γ , or receive treatment.
We assumed that wtCT-infected people in all counties are 
treated at a fixed rate τ  before October 2006. nvCT-infected 
people are treated at the same rate in BD counties, whereas they 
were not treated in AR counties before 2006. We assumed that 
after October 2006, when nvCT was discovered and the AR 
tests were modified, all people with diagnosed CT were treated. 
The increased number of tests after 2006 (online supplementary 
material, figure S2) and reported diagnosis rates could be a result 
of a higher treatment rate directly after the discovery of nvCT.10 
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Figure 1 Deviance information criterion (DIC) values for 21 different 
models, each of which assumes that new variant of Chlamydia 
trachomatis emerged in that county. Red bars are Abbott-Roche (AR) 
counties, blue bars are Becton Dickinson (BD) counties. Intensity of 
shading inversely proportional to DIC.
Figure 2 Data and model fit for proportions of new variant of 
Chlamydia trachomatis (nvCT) in all counties in 2006–2007, after 
the discovery of nvCT (A), proportions of nvCT in Dalarna, Örebro, 
Uppsala and Norrbotten between 2000 and 2015 (B) and number of 
CT diagnoses per 100 000 population in Dalarna, Örebro, Uppsala and 
Norrbotten between 2000 and 2015 (C). Dots and error bars: median 
values and 95% CIs for the data. Bars (A) and trajectories (B, C): model 
outputs. Red bars are Abbott-Roche (AR) counties, blue bars are Becton 
Dickinson (BD) counties.
Figure 3 Rise and fall of new variant of Chlamydia trachomatis (nvCT) 
between 2002 and 2015 in different Swedish counties. The shading 
indicates the proportions of nvCT cases among all CT cases.
We modelled this by assuming that the treatment rate is a certain 
percentage (pi ) higher than τ  directly after the discovery of nvCT, 
and that this percentage decreases linearly to zero within 3 years.
bayesian inference
We obtained posterior distributions of the model parameters by 
fitting the model to two data sets using Bayesian inference (online 
supplementary material). To determine the most likely origin of 
nvCT emergence, we analysed 21 versions of the model; in each 
version, the county in which nvCT emerged differed. We then 
used the deviance information criterion (DIC)18 19 to compare 
the model fits.
sensitivity analyses
We investigated the alternative assumption that a fitness differ-
ence between wtCT and nvCT strains is associated with a relative 
difference in infectious duration instead of a relative difference 
in transmissibility.
rEsulTs
The model version in which nvCT emerged in Dalarna-AR 
(central-Sweden) fitted best to the empirical data, as indicated 
by the lowest DIC value (figure 1). The next best fitting models 
assumed the emergence of nvCT in Gävleborg-AR and Väster-
norrland-AR (also in central Sweden). The remainder of the 
results are from the model assuming emergence in Dalarna.
Overall, the model fitted well to the available empirical data 
about the proportion of nvCT (figure 2). For the 12 counties 
with data just after the discovery of nvCT in late 2006 and early 
2007, the proportion of nvCT was higher in the AR counties 
than in the BD counties (figure 2A). The proportion of nvCT 
in Västra Götaland was less well captured by the model, which 
might result from the mix of BD and AR tests used in different 
laboratories. For the four counties with more frequent data, the 
proportion of nvCT was higher in Dalarna-AR and Örebro-AR 
than in Uppsala-BD and Norrbotten-BD in 2006–2007, after 
nvCT was discovered (figure 2B). By 2015, the proportion of 
nvCT converged to around 5% in all four counties. The model 
also captures trends in diagnoses rates, although there are some 
discrepancies for specific years and counties (figure 2C). In 
particular, the predicted diagnosis rates are lower than the actual 
diagnoses rates for Dalarna-AR after the discovery of nvCT, and 
for Örebro-AR that was the case for 2008 and 2009.
In our model, the posterior distribution of the parameter ∆ 
indicates that nvCT remained undetected for at least 46 months 
(Bayesian credible interval (BCI): 41–56 months) after its intro-
duction until its discovery in October 2006 (table 1). Using 
this estimate, nvCT represented 1% of prevalent infections in 
Dalarna in November 2002 (BCI: January 2002–April 2003) 
(figure 3). By the time that nvCT was discovered in late 2006, 
the model suggests that nvCT had spread to all counties, with 
the highest proportions of nvCT in AR counties (figures 2A and 
3). The rapid growth was primarily driven by the high treatment 
rate in the model, that is, the selective advantage of nvCT of 
not being treated in AR counties. The model-estimated treat-
ment rate (τ  ) was 2.22 (BCI: 1.87–2.49) treatments per infected 
person per year. Infected people can either clear infection natu-
rally at rate  γ  or be treated at rate τ  . Therefore, using the equa-
tion  τ /
(
τ + γ
)
 , we estimated that 75% (BCI: 72%–77%) of the 
wtCT-infected population was treated.
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The observed CT diagnosis rates in AR counties were much 
higher after the discovery of nvCT than before (figure 2C). In the 
model, this observation reflects increased chlamydia prevalence 
after emergence of nvCT because people in AR counties with 
undiagnosed nvCT did not receive treatment until 2006. The 
parameter pi (increase in testing rate τ  from 2006 to 2009, after 
discovery of nvCT) in the model represents increased testing. 
In the model, pi was estimated at close to zero, so increased 
transmission alone could account for the increase in diagnosis 
rates. In reality, the increase in testing that occurred in Sweden 
in 2007, might also have contributed to this increase.
From 2007, the proportion of nvCT and the diagnosis rates 
decreased in all counties. We estimated that nvCT was 5% (BCI: 
4%–6%) less transmissible than wtCT strains. In the sensitivity 
analysis where we assumed that the fitness cost could also be 
associated with infectious duration, we estimated a 17% (BCI: 
16%–19%) reduction in infectious duration for nvCT compared 
with wtCT strains (online supplementary material, figure S4). In 
both cases, the reduced fitness of nvCT and its dilution across 
counties, together with the loss of the diagnostic selective advan-
tage, led to the decline in its proportion after its discovery. This 
process can also be quantified by R0, which we computed for 
wtCT and nvCT in presence and absence of effective testing and 
treatment (online supplementary material, S3). R0 for wtCT is 
slightly above the threshold of one (1.06, BCI: 1.04–1.06). R0 
for nvCT before its discovery is considerably higher (4.06, BCI: 
3.62–4.37), owing to the diagnostic selective advantage of nvCT 
compared with wtCT. In contrast, R0 for nvCT after its discovery 
is lower (1.00, BCI: 0.99–1.02), owing to its reduced transmissi-
bility and the lost diagnostic selective advantage.
dIsCussIOn
Using a mathematical model, we were able to reconstruct the 
course of a natural experiment in which a mutant strain of 
C. trachomatis escaped detection and spread across Sweden. 
According to our model, the nvCT emerged in central Sweden 
(Dalarna, Gävleborg, Västernorrland), reaching a proportion of 
1% of prevalent CT infections in late 2002 or early 2003. The 
diagnostic selective advantage of nvCT enabled its rapid spread in 
the presence of high CT treatment and transmission rates. After 
detection, the proportion of nvCT decreased from 30%–70% 
in AR counties and 5%–20% in BD counties to around 5% in 
2015 in all counties because of between-county mixing and the 
subsequent dilution of nvCT. Our modelling results suggest that 
this decline is consistent with the lost diagnostic selective advan-
tage and reduced fitness of the nvCT, either because of reduced 
transmissibility by around 5%, or reduced infectious duration 
by around 17%. Our modelling study for the first time provides 
support of a reduced transmissibility or infectious duration of 
nvCT.
The strengths of the model are that it is relatively simple, but 
incorporates necessary heterogeneity in mixing between groups 
with differing levels of sexual activity and between different 
geographical areas. There were sufficient empirical data about 
the proportion of nvCT after its discovery and more detailed 
data in both AR and BD counties to fit the model. Our study 
also has a number of limitations that need to be considered when 
interpreting the findings. First, we had to make some simplifying 
assumptions about the structure and parameters of the transmis-
sion model. Owing to the limits of the Markov Chain Monte 
Carlo (MCMC) inference framework, we decided to use fixed 
values for the sexual partner change rates and the chlamydia 
clearance rate. There is considerable uncertainty with regard to 
the exact values of these parameters, which might explain the 
relatively high posterior values of the per-partnership transmis-
sion probability, and the finding that sexual mixing between 
activity classes is close to random. However, the differential 
spread of wtCT and nvCT is mainly driven by the detection/
treatment rate and the fitness cost and we previously showed 
that the transmission probability and mixing coefficient only 
marginally influence the relative spread of different strains of 
STIs.9 The relatively simple model structure makes the modelled 
prevalence sensitive to small changes in the transmission 
dynamics. While our model can describe changes in the propor-
tion of nvCT well, it does not necessarily generate reliable esti-
mates of incidence and prevalence. Second, we did not model 
the possibility that factors other than the spread of nvCT, such 
as increased incidence or changes in screening policy, might have 
contributed to an increase in overall CT prevalence in Sweden.20 
Third, we used a deterministic model. While very unlikely, nvCT 
could have emerged independently in multiple unrelated people, 
possibly in different counties and at different times. Modelling 
these possibilities in more detail would require a stochastic 
modelling framework. The choice of a deterministic model did 
not affect parameter inference, because we only used data for 
years when there was a substantial proportion of nvCT. Model-
ling stochasticity in these circumstances is less important.15 
Furthermore, extensive genotyping of nvCT cases from different 
time points and countries support a clonal spread of nvCT.3 7 21 22 
Finally, we did not include the possibility of acquired immunity 
in our model. More untreated infections in AB counties could 
have resulted in higher levels of immunity in the population. It 
is unclear how this would have affected the differential spread 
of nvCT and wtCT.
The emergence of nvCT in Sweden was, to our knowledge, the 
first reported example of a strain mutating to escape detection by 
a diagnostic test, but was not unique. In May 2019, researchers 
in Finland reported false-negative chlamydia test results using 
the Aptima Combo 2 test, resulting from a single point mutation 
in the 23 s rRNA gene.23 24 These events in the field of diagnos-
tics can be compared with the phenomenon of immune escape, 
where viral pathogens such as HIV evade recognition by cyto-
toxic T lymphocytes through mutation in their epitopes.25 The 
emergence of nvCT is also related to the mechanisms that facil-
itate the spread of antimicrobial resistance for other STIs. High 
treatment rates are the major driver for the spread of Neisseria 
gonorrhoeae strains that are resistant to antimicrobials such as 
ciprofloxacin.9 26 Antimicrobial resistance in CT has not been 
detected yet, but its possible emergence cannot be excluded 
with continued antimicrobial selection pressure.27 Our estimate 
that around three-quarters of infected people receive treatment 
(online supplementary material, S5) is consistent with the history 
of early introduction of widespread opportunistic testing and an 
advanced system of partner notification that identifies recent 
sex partners with a high probability of CT.28 29 The insights into 
the means by which competition between CT strains, through 
selection pressure induced by testing and treatment, can inform 
the future study of the potential for the spread of antimicrobial 
resistance in CT. Increased levels of STI testing with molecular 
diagnostic methods mean that mutations that affect the target 
sequences for nucleic acid amplification provide new evolu-
tionary advantages for C. trachomatis and other pathogens.
This modelling study provides insights into the spread of 
nvCT in Sweden that are consistent with the evidence obtained 
from epidemiological and genomic studies. Our study shows the 
value of high-quality surveillance data and of the prompt inves-
tigation and follow-up of anomalies in these data. The estimated 
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year of emergence agrees with retrospective analyses that first 
detected nvCT in 2003,4 with presumed emergence between 
2001–2002 and 2003–20046 and absence of detection of nvCT 
before 2002.5 In addition, our study indicates that nvCT was 
associated with a fitness cost at the population level, which 
resulted in reduced transmission. In vitro studies showed that 
nvCT had unaltered fitness compared with all examined wtCT 
strains.5 However, small-scale gene variations and/or alterations 
in timing and level of gene transcription and translation affecting 
the fitness in vivo or in vitro, could not be excluded.5 Also, 
fitness as measured by in vitro growth assays is not necessarily 
related to fitness at the population level, as expressed by R0. In 
conclusion, our model results quantified the speed of spread 
of C. trachomatis in the absence of testing and treatment. This 
mathematical model improved our understanding of the first 
nvCT epidemic in Sweden and can be adapted to investigate the 
impact of future diagnostic escape mutants.
Key messages
 ► The dynamics of a new variant of Chlamydia trachomatis 
(nvCT) that escaped testing and treatment in Sweden can be 
reconstructed using a mathematical transmission model.
 ► Our study for the first time provides support of a reduced 
transmissibility or infectious duration of the nvCT in Sweden.
 ► This mathematical model improved our understanding of the 
nvCT epidemic in Sweden and can be adapted to investigate 
the impact of future diagnostic escape mutants.
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